Lennart ZABEAU
14Patents
4h-index
10Co-inventors
57Inventor score
Filing activity: Oct 29, 2001 → Oct 5, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9732135B2 | Targeting of human interferon antagonists | Chemistry; Metallurgy | 16 | Active |
| US10072059B2 | Targeting of human interferon antagonists | Chemistry; Metallurgy | 13 | Active |
| US7575878B2 | Methods of inhibiting leptin-induced signaling with fibronectin III domain antibodies | Chemistry; Metallurgy | 12 | Expired |
| US10906985B2 | Targeted engineered interferon and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US11084859B2 | Targeted mutant interferon-gamma and uses thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US10947288B2 | Targeting of human interferon antagonists | Chemistry; Metallurgy | 3 | Active |
| US7235629B2 | Functional fragment of the leptin receptor | Human Necessities | 3 | Expired |
| US11498966B2 | PD-1 and PD-L1 binding agents | Chemistry; Metallurgy | 0 | Active |
| US11440943B2 | Therapeutic interferon alpha 1 proteins | Chemistry; Metallurgy | 0 | Active |
| US12410225B2 | Modulation of dendritic cell lineages | Chemistry; Metallurgy | 0 | Active |
| US12351633B2 | PD-1 and PD-L1 binding agents | Chemistry; Metallurgy | 0 | Active |
| US12351614B2 | CLEC9A-based chimeric protein complexes | Chemistry; Metallurgy | 0 | Active |
| US11566072B2 | CD8 binding agents | Chemistry; Metallurgy | 0 | Active |
| US12091463B2 | Clec9A binding agents comprising a recombinant heavy-chain only antibody (VHH) | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.